See also
ˇ Show More
The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
You have visited 10 password protected pages for free. Others contain data covered by
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Pfizer Inc., Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
USD $ in millions

| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
![]() |
Short-term borrowings, including current portion of long-term debt | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Accounts payable | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dividends payable | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Income taxes payable | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Accrued compensation and related items | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other current liabilities | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Current liabilities | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Long-term debt, excluding current portion | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Pension benefit obligations | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Postretirement benefit obligations | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Noncurrent deferred tax liabilities | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other taxes payable | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other noncurrent liabilities | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Noncurrent liabilities | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Total liabilities | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Preferred stock, without par value, at stated value | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Common stock, $0.05 par value | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Additional paid-in capital | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Employee benefit trusts | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Treasury stock, shares at cost | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Retained earnings | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Accumulated other comprehensive income (loss) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Pfizer Inc. shareholders’ equity | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Equity attributable to noncontrolling interests | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Total shareholders’ equity | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Total liabilities and shareholders’ equity | ![]() |
![]() |
![]() |
![]() |
![]() |
| Item | Description | The company |
|---|---|---|
| Accounts payable | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | Pfizer Inc.'s accounts payable declined from 2009 to 2010 and from 2010 to 2011. |
| Current liabilities | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | Pfizer Inc.'s current liabilities declined from 2009 to 2010 and from 2010 to 2011. |
| Noncurrent liabilities | Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle. | Pfizer Inc.'s noncurrent liabilities declined from 2009 to 2010 and from 2010 to 2011. |
| Total liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | Pfizer Inc.'s total liabilities declined from 2009 to 2010 and from 2010 to 2011. |
| Pfizer Inc. shareholders’ equity | Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). | Pfizer Inc.'s pfizer Inc. shareholders’ equity declined from 2009 to 2010 and from 2010 to 2011. |
| Total shareholders’ equity | Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. | Pfizer Inc.'s total shareholders’ equity declined from 2009 to 2010 and from 2010 to 2011. |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center